Global Antibiotic Sensitivity Testing Market

Antibiotic Sensitivity Testing Comprehensive Study by Type (Automated Laboratory Instruments, Manual Antimicrobial Susceptibility Testing Products, Susceptibility Testing Disks, MIC strips, Susceptibility Plates, Culture and Growth Media, Consumables), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology, Others), Testing Type (Antibacterial, Antifungal, Antiparasitic, Others), End-User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research &Academic Institutes, Clinical Research Organizations (CROs)), Method (Dilution, Disk Diffusion, ETEST, Automated Antimicrobial Susceptibility Testing, Genotypic Methods) Players and Region - Global Market Outlook to 2027

Antibiotic Sensitivity Testing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
AntibioticSensitivity testing is a technique for determining whether or not a single organism or group of organisms is susceptible to an antibiotic. The most commonly used research methods for determining Antibiotic susceptibility are broth microdilution or rapid automated instrument methods. Commercially, these techniques are used and sold for products and equipment. It also aids in the evaluation of therapeutic services provided by hospitals, national initiatives, and clinics around the world in order to control and prevent infectious diseases. Various researchers have recently introduced continuous surveillance over behaviors to study the patterns of resistance to bacterial DNA mutations. Antibiotic resistance tests identify bacteria or fungi, as well as their antibody sensitivity. This testing is normally performed with a Gram stain and culture, which allows for faster results. Antibiotic susceptibility testing also assists the physician in selecting the appropriate medication and dose for the infection.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledbioMérieux SA (France), Becton, Dickinson, and Company (United States), Thermo Fisher Scientific (United States), Cepheid (United States), Bio-Rad Laboratories, Inc. (United States), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (United States), Merck KGaA (United States), Hi-Media Laboratories (India) and LiofilchemS.r.l. (Italy)


This growth is primarily driven by Increasing Prevalence of Multi-Drug Resistance Organisms and Rising Use of Antimicrobial Susceptibility Testing by Pharmaceutical Companies.

Globally, a noticeable market trend is evident Growing Awareness of Precision Medicine Major Players, such as bioMérieux SA (France), Becton, Dickinson, and Company (United States), Thermo Fisher Scientific (United States), Cepheid (United States), Bio-Rad Laboratories, Inc. (United States), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (United States), Merck KGaA (United States), Hi-Media Laboratories (India) and LiofilchemS.r.l. (Italy) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

March 2020 – Cepheid announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert Xpress SARS-CoV-2, a rapid molecular diagnostic test for qualitative detection of SARS-CoV-2, the virus causing COVID-19. The test has been designed to operate on any of Cepheid's more than 23,000 automated GeneXpert Systems worldwide, with a detection time of approximately 45 minutes.

Antibiotic Sensitivity Testing Market Dynamics:
AttributesDetails
Growth Drivers
  • Increasing Prevalence of Multi-Drug Resistance Organisms
  • Rising Use of Antimicrobial Susceptibility Testing by Pharmaceutical Companies
Influencing Trends
  • Growing Awareness of Precision Medicine
  • The Rising Global Burden of Infectious Diseases
Restraints
  • Unavailability of Medical Reimbursements For Microbial Testing Procedures
  • High Associated Costs
Gaps & Opportunities
  • Increasing Funding, Research Grants, and Public-Private Investments in the Market
  • Growing government initiatives to detect and control antimicrobial-resistant species


AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Antibiotic Sensitivity Testing Market
- Analysis about New Entrants in Antibiotic Sensitivity Testing Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Antibiotic Sensitivity Testing Study Sheds Light on
— The Antibiotic Sensitivity Testing Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Antibiotic Sensitivity Testing industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Antibiotic Sensitivity Testing industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Automated Laboratory Instruments
  • Manual Antimicrobial Susceptibility Testing Products
  • Susceptibility Testing Disks
  • MIC strips
  • Susceptibility Plates
  • Culture and Growth Media
  • Consumables
By Application
  • Clinical Diagnostics
  • Drug Discovery and Development
  • Epidemiology
  • Others
By Testing Type
  • Antibacterial
  • Antifungal
  • Antiparasitic
  • Others

By End-User
  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Research &Academic Institutes
  • Clinical Research Organizations (CROs)

By Method
  • Dilution
  • Disk Diffusion
  • ETEST
  • Automated Antimicrobial Susceptibility Testing
  • Genotypic Methods

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Multi-Drug Resistance Organisms
      • 3.2.2. Rising Use of Antimicrobial Susceptibility Testing by Pharmaceutical Companies
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulatory Policies
    • 3.4. Market Trends
      • 3.4.1. Growing Awareness of Precision Medicine
      • 3.4.2. The Rising Global Burden of Infectious Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibiotic Sensitivity Testing, by Type, Application, Testing Type, End-User, Method and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Antibiotic Sensitivity Testing (Value)
      • 5.2.1. Global Antibiotic Sensitivity Testing by: Type (Value)
        • 5.2.1.1. Automated Laboratory Instruments
        • 5.2.1.2. Manual Antimicrobial Susceptibility Testing Products
        • 5.2.1.3. Susceptibility Testing Disks
        • 5.2.1.4. MIC strips
        • 5.2.1.5. Susceptibility Plates
        • 5.2.1.6. Culture and Growth Media
        • 5.2.1.7. Consumables
      • 5.2.2. Global Antibiotic Sensitivity Testing by: Application (Value)
        • 5.2.2.1. Clinical Diagnostics
        • 5.2.2.2. Drug Discovery and Development
        • 5.2.2.3. Epidemiology
        • 5.2.2.4. Others
      • 5.2.3. Global Antibiotic Sensitivity Testing by: Testing Type (Value)
        • 5.2.3.1. Antibacterial
        • 5.2.3.2. Antifungal
        • 5.2.3.3. Antiparasitic
        • 5.2.3.4. Others
      • 5.2.4. Global Antibiotic Sensitivity Testing by: End-User (Value)
        • 5.2.4.1. Hospitals and Diagnostic Centers
        • 5.2.4.2. Pharmaceutical and Biotechnology Companies
        • 5.2.4.3. Research &Academic Institutes
        • 5.2.4.4. Clinical Research Organizations (CROs)
      • 5.2.5. Global Antibiotic Sensitivity Testing by: Method (Value)
        • 5.2.5.1. Dilution
        • 5.2.5.2. Disk Diffusion
        • 5.2.5.3. ETEST
        • 5.2.5.4. Automated Antimicrobial Susceptibility Testing
        • 5.2.5.5. Genotypic Methods
      • 5.2.6. Global Antibiotic Sensitivity Testing Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Antibiotic Sensitivity Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioMérieux SA (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson, and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cepheid (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Roche Diagnostics Limited (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Accelerate Diagnostics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merck KGaA (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hi-Media Laboratories (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LiofilchemS.r.l. (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antibiotic Sensitivity Testing Sale, by Type, Application, Testing Type, End-User, Method and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Antibiotic Sensitivity Testing (Value)
      • 7.2.1. Global Antibiotic Sensitivity Testing by: Type (Value)
        • 7.2.1.1. Automated Laboratory Instruments
        • 7.2.1.2. Manual Antimicrobial Susceptibility Testing Products
        • 7.2.1.3. Susceptibility Testing Disks
        • 7.2.1.4. MIC strips
        • 7.2.1.5. Susceptibility Plates
        • 7.2.1.6. Culture and Growth Media
        • 7.2.1.7. Consumables
      • 7.2.2. Global Antibiotic Sensitivity Testing by: Application (Value)
        • 7.2.2.1. Clinical Diagnostics
        • 7.2.2.2. Drug Discovery and Development
        • 7.2.2.3. Epidemiology
        • 7.2.2.4. Others
      • 7.2.3. Global Antibiotic Sensitivity Testing by: Testing Type (Value)
        • 7.2.3.1. Antibacterial
        • 7.2.3.2. Antifungal
        • 7.2.3.3. Antiparasitic
        • 7.2.3.4. Others
      • 7.2.4. Global Antibiotic Sensitivity Testing by: End-User (Value)
        • 7.2.4.1. Hospitals and Diagnostic Centers
        • 7.2.4.2. Pharmaceutical and Biotechnology Companies
        • 7.2.4.3. Research &Academic Institutes
        • 7.2.4.4. Clinical Research Organizations (CROs)
      • 7.2.5. Global Antibiotic Sensitivity Testing by: Method (Value)
        • 7.2.5.1. Dilution
        • 7.2.5.2. Disk Diffusion
        • 7.2.5.3. ETEST
        • 7.2.5.4. Automated Antimicrobial Susceptibility Testing
        • 7.2.5.5. Genotypic Methods
      • 7.2.6. Global Antibiotic Sensitivity Testing Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibiotic Sensitivity Testing: by Type(USD Million)
  • Table 2. Antibiotic Sensitivity Testing Automated Laboratory Instruments , by Region USD Million (2016-2021)
  • Table 3. Antibiotic Sensitivity Testing Manual Antimicrobial Susceptibility Testing Products , by Region USD Million (2016-2021)
  • Table 4. Antibiotic Sensitivity Testing Susceptibility Testing Disks , by Region USD Million (2016-2021)
  • Table 5. Antibiotic Sensitivity Testing MIC strips , by Region USD Million (2016-2021)
  • Table 6. Antibiotic Sensitivity Testing Susceptibility Plates , by Region USD Million (2016-2021)
  • Table 7. Antibiotic Sensitivity Testing Culture and Growth Media , by Region USD Million (2016-2021)
  • Table 8. Antibiotic Sensitivity Testing Consumables , by Region USD Million (2016-2021)
  • Table 9. Antibiotic Sensitivity Testing: by Application(USD Million)
  • Table 10. Antibiotic Sensitivity Testing Clinical Diagnostics , by Region USD Million (2016-2021)
  • Table 11. Antibiotic Sensitivity Testing Drug Discovery and Development , by Region USD Million (2016-2021)
  • Table 12. Antibiotic Sensitivity Testing Epidemiology , by Region USD Million (2016-2021)
  • Table 13. Antibiotic Sensitivity Testing Others , by Region USD Million (2016-2021)
  • Table 14. Antibiotic Sensitivity Testing: by Testing Type(USD Million)
  • Table 15. Antibiotic Sensitivity Testing Antibacterial , by Region USD Million (2016-2021)
  • Table 16. Antibiotic Sensitivity Testing Antifungal , by Region USD Million (2016-2021)
  • Table 17. Antibiotic Sensitivity Testing Antiparasitic , by Region USD Million (2016-2021)
  • Table 18. Antibiotic Sensitivity Testing Others , by Region USD Million (2016-2021)
  • Table 19. Antibiotic Sensitivity Testing: by End-User(USD Million)
  • Table 20. Antibiotic Sensitivity Testing Hospitals and Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 21. Antibiotic Sensitivity Testing Pharmaceutical and Biotechnology Companies , by Region USD Million (2016-2021)
  • Table 22. Antibiotic Sensitivity Testing Research &Academic Institutes , by Region USD Million (2016-2021)
  • Table 23. Antibiotic Sensitivity Testing Clinical Research Organizations (CROs) , by Region USD Million (2016-2021)
  • Table 24. Antibiotic Sensitivity Testing: by Method(USD Million)
  • Table 25. Antibiotic Sensitivity Testing Dilution , by Region USD Million (2016-2021)
  • Table 26. Antibiotic Sensitivity Testing Disk Diffusion , by Region USD Million (2016-2021)
  • Table 27. Antibiotic Sensitivity Testing ETEST , by Region USD Million (2016-2021)
  • Table 28. Antibiotic Sensitivity Testing Automated Antimicrobial Susceptibility Testing , by Region USD Million (2016-2021)
  • Table 29. Antibiotic Sensitivity Testing Genotypic Methods , by Region USD Million (2016-2021)
  • Table 30. South America Antibiotic Sensitivity Testing, by Country USD Million (2016-2021)
  • Table 31. South America Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 32. South America Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 33. South America Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 34. South America Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 35. South America Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 36. Brazil Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 37. Brazil Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 38. Brazil Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 39. Brazil Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 40. Brazil Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 41. Argentina Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 42. Argentina Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 43. Argentina Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 44. Argentina Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 45. Argentina Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 46. Rest of South America Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 47. Rest of South America Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 48. Rest of South America Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 49. Rest of South America Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 50. Rest of South America Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 51. Asia Pacific Antibiotic Sensitivity Testing, by Country USD Million (2016-2021)
  • Table 52. Asia Pacific Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 53. Asia Pacific Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 54. Asia Pacific Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 55. Asia Pacific Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 56. Asia Pacific Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 57. China Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 58. China Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 59. China Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 60. China Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 61. China Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 62. Japan Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 63. Japan Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 64. Japan Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 65. Japan Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 66. Japan Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 67. India Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 68. India Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 69. India Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 70. India Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 71. India Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 72. South Korea Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 73. South Korea Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 74. South Korea Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 75. South Korea Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 76. South Korea Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 77. Taiwan Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 78. Taiwan Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 79. Taiwan Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 80. Taiwan Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 81. Taiwan Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 82. Australia Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 83. Australia Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 84. Australia Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 85. Australia Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 86. Australia Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 87. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 88. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 89. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 90. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 91. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 92. Europe Antibiotic Sensitivity Testing, by Country USD Million (2016-2021)
  • Table 93. Europe Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 94. Europe Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 95. Europe Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 96. Europe Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 97. Europe Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 98. Germany Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 99. Germany Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 100. Germany Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 101. Germany Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 102. Germany Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 103. France Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 104. France Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 105. France Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 106. France Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 107. France Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 108. Italy Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 109. Italy Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 110. Italy Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 111. Italy Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 112. Italy Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 113. United Kingdom Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 114. United Kingdom Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 115. United Kingdom Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 116. United Kingdom Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 117. United Kingdom Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 118. Netherlands Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 119. Netherlands Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 120. Netherlands Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 121. Netherlands Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 122. Netherlands Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 123. Rest of Europe Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 124. Rest of Europe Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 125. Rest of Europe Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 126. Rest of Europe Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 127. Rest of Europe Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 128. MEA Antibiotic Sensitivity Testing, by Country USD Million (2016-2021)
  • Table 129. MEA Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 130. MEA Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 131. MEA Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 132. MEA Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 133. MEA Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 134. Middle East Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 135. Middle East Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 136. Middle East Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 137. Middle East Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 138. Middle East Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 139. Africa Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 140. Africa Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 141. Africa Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 142. Africa Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 143. Africa Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 144. North America Antibiotic Sensitivity Testing, by Country USD Million (2016-2021)
  • Table 145. North America Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 146. North America Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 147. North America Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 148. North America Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 149. North America Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 150. United States Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 151. United States Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 152. United States Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 153. United States Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 154. United States Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 155. Canada Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 156. Canada Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 157. Canada Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 158. Canada Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 159. Canada Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 160. Mexico Antibiotic Sensitivity Testing, by Type USD Million (2016-2021)
  • Table 161. Mexico Antibiotic Sensitivity Testing, by Application USD Million (2016-2021)
  • Table 162. Mexico Antibiotic Sensitivity Testing, by Testing Type USD Million (2016-2021)
  • Table 163. Mexico Antibiotic Sensitivity Testing, by End-User USD Million (2016-2021)
  • Table 164. Mexico Antibiotic Sensitivity Testing, by Method USD Million (2016-2021)
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Antibiotic Sensitivity Testing: by Type(USD Million)
  • Table 176. Antibiotic Sensitivity Testing Automated Laboratory Instruments , by Region USD Million (2022-2027)
  • Table 177. Antibiotic Sensitivity Testing Manual Antimicrobial Susceptibility Testing Products , by Region USD Million (2022-2027)
  • Table 178. Antibiotic Sensitivity Testing Susceptibility Testing Disks , by Region USD Million (2022-2027)
  • Table 179. Antibiotic Sensitivity Testing MIC strips , by Region USD Million (2022-2027)
  • Table 180. Antibiotic Sensitivity Testing Susceptibility Plates , by Region USD Million (2022-2027)
  • Table 181. Antibiotic Sensitivity Testing Culture and Growth Media , by Region USD Million (2022-2027)
  • Table 182. Antibiotic Sensitivity Testing Consumables , by Region USD Million (2022-2027)
  • Table 183. Antibiotic Sensitivity Testing: by Application(USD Million)
  • Table 184. Antibiotic Sensitivity Testing Clinical Diagnostics , by Region USD Million (2022-2027)
  • Table 185. Antibiotic Sensitivity Testing Drug Discovery and Development , by Region USD Million (2022-2027)
  • Table 186. Antibiotic Sensitivity Testing Epidemiology , by Region USD Million (2022-2027)
  • Table 187. Antibiotic Sensitivity Testing Others , by Region USD Million (2022-2027)
  • Table 188. Antibiotic Sensitivity Testing: by Testing Type(USD Million)
  • Table 189. Antibiotic Sensitivity Testing Antibacterial , by Region USD Million (2022-2027)
  • Table 190. Antibiotic Sensitivity Testing Antifungal , by Region USD Million (2022-2027)
  • Table 191. Antibiotic Sensitivity Testing Antiparasitic , by Region USD Million (2022-2027)
  • Table 192. Antibiotic Sensitivity Testing Others , by Region USD Million (2022-2027)
  • Table 193. Antibiotic Sensitivity Testing: by End-User(USD Million)
  • Table 194. Antibiotic Sensitivity Testing Hospitals and Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 195. Antibiotic Sensitivity Testing Pharmaceutical and Biotechnology Companies , by Region USD Million (2022-2027)
  • Table 196. Antibiotic Sensitivity Testing Research &Academic Institutes , by Region USD Million (2022-2027)
  • Table 197. Antibiotic Sensitivity Testing Clinical Research Organizations (CROs) , by Region USD Million (2022-2027)
  • Table 198. Antibiotic Sensitivity Testing: by Method(USD Million)
  • Table 199. Antibiotic Sensitivity Testing Dilution , by Region USD Million (2022-2027)
  • Table 200. Antibiotic Sensitivity Testing Disk Diffusion , by Region USD Million (2022-2027)
  • Table 201. Antibiotic Sensitivity Testing ETEST , by Region USD Million (2022-2027)
  • Table 202. Antibiotic Sensitivity Testing Automated Antimicrobial Susceptibility Testing , by Region USD Million (2022-2027)
  • Table 203. Antibiotic Sensitivity Testing Genotypic Methods , by Region USD Million (2022-2027)
  • Table 204. South America Antibiotic Sensitivity Testing, by Country USD Million (2022-2027)
  • Table 205. South America Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 206. South America Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 207. South America Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 208. South America Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 209. South America Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 210. Brazil Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 211. Brazil Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 212. Brazil Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 213. Brazil Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 214. Brazil Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 215. Argentina Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 216. Argentina Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 217. Argentina Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 218. Argentina Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 219. Argentina Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 220. Rest of South America Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 221. Rest of South America Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 222. Rest of South America Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 223. Rest of South America Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 224. Rest of South America Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 225. Asia Pacific Antibiotic Sensitivity Testing, by Country USD Million (2022-2027)
  • Table 226. Asia Pacific Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 227. Asia Pacific Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 228. Asia Pacific Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 229. Asia Pacific Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 230. Asia Pacific Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 231. China Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 232. China Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 233. China Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 234. China Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 235. China Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 236. Japan Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 237. Japan Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 238. Japan Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 239. Japan Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 240. Japan Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 241. India Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 242. India Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 243. India Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 244. India Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 245. India Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 246. South Korea Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 247. South Korea Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 248. South Korea Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 249. South Korea Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 250. South Korea Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 251. Taiwan Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 252. Taiwan Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 253. Taiwan Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 254. Taiwan Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 255. Taiwan Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 256. Australia Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 257. Australia Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 258. Australia Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 259. Australia Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 260. Australia Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 261. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 262. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 263. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 264. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 265. Rest of Asia-Pacific Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 266. Europe Antibiotic Sensitivity Testing, by Country USD Million (2022-2027)
  • Table 267. Europe Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 268. Europe Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 269. Europe Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 270. Europe Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 271. Europe Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 272. Germany Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 273. Germany Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 274. Germany Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 275. Germany Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 276. Germany Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 277. France Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 278. France Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 279. France Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 280. France Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 281. France Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 282. Italy Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 283. Italy Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 284. Italy Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 285. Italy Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 286. Italy Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 287. United Kingdom Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 288. United Kingdom Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 289. United Kingdom Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 290. United Kingdom Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 291. United Kingdom Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 292. Netherlands Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 293. Netherlands Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 294. Netherlands Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 295. Netherlands Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 296. Netherlands Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 297. Rest of Europe Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 298. Rest of Europe Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 299. Rest of Europe Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 300. Rest of Europe Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 301. Rest of Europe Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 302. MEA Antibiotic Sensitivity Testing, by Country USD Million (2022-2027)
  • Table 303. MEA Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 304. MEA Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 305. MEA Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 306. MEA Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 307. MEA Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 308. Middle East Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 309. Middle East Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 310. Middle East Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 311. Middle East Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 312. Middle East Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 313. Africa Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 314. Africa Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 315. Africa Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 316. Africa Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 317. Africa Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 318. North America Antibiotic Sensitivity Testing, by Country USD Million (2022-2027)
  • Table 319. North America Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 320. North America Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 321. North America Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 322. North America Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 323. North America Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 324. United States Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 325. United States Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 326. United States Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 327. United States Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 328. United States Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 329. Canada Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 330. Canada Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 331. Canada Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 332. Canada Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 333. Canada Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 334. Mexico Antibiotic Sensitivity Testing, by Type USD Million (2022-2027)
  • Table 335. Mexico Antibiotic Sensitivity Testing, by Application USD Million (2022-2027)
  • Table 336. Mexico Antibiotic Sensitivity Testing, by Testing Type USD Million (2022-2027)
  • Table 337. Mexico Antibiotic Sensitivity Testing, by End-User USD Million (2022-2027)
  • Table 338. Mexico Antibiotic Sensitivity Testing, by Method USD Million (2022-2027)
  • Table 339. Research Programs/Design for This Report
  • Table 340. Key Data Information from Secondary Sources
  • Table 341. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibiotic Sensitivity Testing: by Type USD Million (2016-2021)
  • Figure 5. Global Antibiotic Sensitivity Testing: by Application USD Million (2016-2021)
  • Figure 6. Global Antibiotic Sensitivity Testing: by Testing Type USD Million (2016-2021)
  • Figure 7. Global Antibiotic Sensitivity Testing: by End-User USD Million (2016-2021)
  • Figure 8. Global Antibiotic Sensitivity Testing: by Method USD Million (2016-2021)
  • Figure 9. South America Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 10. Asia Pacific Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 11. Europe Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 12. MEA Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 13. North America Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 14. Global Antibiotic Sensitivity Testing share by Players 2021 (%)
  • Figure 15. Global Antibiotic Sensitivity Testing share by Players (Top 3) 2021(%)
  • Figure 16. Global Antibiotic Sensitivity Testing share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 19. BioMérieux SA (France) Revenue: by Geography 2021
  • Figure 20. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 21. Becton, Dickinson, and Company (United States) Revenue: by Geography 2021
  • Figure 22. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 23. Thermo Fisher Scientific (United States) Revenue: by Geography 2021
  • Figure 24. Cepheid (United States) Revenue, Net Income and Gross profit
  • Figure 25. Cepheid (United States) Revenue: by Geography 2021
  • Figure 26. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 28. Roche Diagnostics Limited (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Roche Diagnostics Limited (Switzerland) Revenue: by Geography 2021
  • Figure 30. Accelerate Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Accelerate Diagnostics, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Merck KGaA (United States) Revenue, Net Income and Gross profit
  • Figure 33. Merck KGaA (United States) Revenue: by Geography 2021
  • Figure 34. Hi-Media Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 35. Hi-Media Laboratories (India) Revenue: by Geography 2021
  • Figure 36. LiofilchemS.r.l. (Italy) Revenue, Net Income and Gross profit
  • Figure 37. LiofilchemS.r.l. (Italy) Revenue: by Geography 2021
  • Figure 38. Global Antibiotic Sensitivity Testing: by Type USD Million (2022-2027)
  • Figure 39. Global Antibiotic Sensitivity Testing: by Application USD Million (2022-2027)
  • Figure 40. Global Antibiotic Sensitivity Testing: by Testing Type USD Million (2022-2027)
  • Figure 41. Global Antibiotic Sensitivity Testing: by End-User USD Million (2022-2027)
  • Figure 42. Global Antibiotic Sensitivity Testing: by Method USD Million (2022-2027)
  • Figure 43. South America Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 44. Asia Pacific Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 45. Europe Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 46. MEA Antibiotic Sensitivity Testing Share (%), by Country
  • Figure 47. North America Antibiotic Sensitivity Testing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • bioMérieux SA (France)
  • Becton, Dickinson, and Company (United States)
  • Thermo Fisher Scientific (United States)
  • Cepheid (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Roche Diagnostics Limited (Switzerland)
  • Accelerate Diagnostics, Inc. (United States)
  • Merck KGaA (United States)
  • Hi-Media Laboratories (India)
  • LiofilchemS.r.l. (Italy)
Additional players considered in the study are as follows:
ZHUHAI DL BIOTECH Co., Ltd. (China) , Mast Group Ltd. (United Kingdom) , CONDALAB (Spain)
Select User Access Type

Key Highlights of Report


Jul 2022 161 Pages 67 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antibiotic Sensitivity Testing Market Quantitative research analysis
Global Antibiotic Sensitivity Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Antibiotic Sensitivity Testing market are bioMérieux SA (France), Becton, Dickinson, and Company (United States), Thermo Fisher Scientific (United States), Cepheid (United States), Bio-Rad Laboratories, Inc. (United States), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (United States), Merck KGaA (United States), Hi-Media Laboratories (India) and LiofilchemS.r.l. (Italy), to name a few.
is dominating the Antibiotic Sensitivity Testing Market.
"Stringent Government Regulatory Policies" is seen as one of major challenge by many Industry Players of Antibiotic Sensitivity Testing Market
The Antibiotic Sensitivity Testing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Antibiotic Sensitivity Testing market is expected to see a steady growth rate during projected year 2021 to 2027.

Know More About Global Antibiotic Sensitivity Testing Market Report?

Have a Query? Click Here

Other Related Reports

Biolistic Particle Delivery System Comprehensive Study by Application (Genetic vaccination, Cancer gene therapy, Immunomodulation, Genetic pharmacology, Others), Modality (Portable, Fixed), End User ...
$ 3450
Pertussis Vaccines Comprehensive Study by Type (Whole-Cell Vaccines, A-Cellular Vaccines), Application (Pediatrics, Adults), Vaccine Type (DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Qu...
$ 3450
Body Plethysmography Comprehensive Study by Type (Whole Body, Part of Body), Application (Adults, Kids), End-User (Hospitals, Fitness centers, Academic & Research centres, Others) Players and Region ...
$ 3500
Bispecific Antibodies Comprehensive Study by Type (Trifunctional Antibodies, Chemically Linked Fabs, Bispecific T Cell Engagers (BiTEs).), Application (Hospitals, Diagnostic Centers, Academic and Res...
$ 3750
Automated Gram Stainer Comprehensive Study by Application (In-house Research, Commercial Research, Clinical Diagnosis), Slide Capacity (Upto 12 Slide, 13 - 30 slides, 31 -50 slides, Above 50 slides),...
$ 3650
Cellular Therapy in Oncology Comprehensive Study by Type (Consumables, Equipment (Cell Processing Equipment, Single-use Equipment), Systems & Software), Technology (Bioreactor, Cell Immortalization T...
$ 3750